California State Teachers Retirement System Sarepta Therapeutics, Inc. Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 80,921 shares of SRPT stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
80,921
Previous 82,945 2.44%
Holding current value
$10.3 Million
Previous $13.1 Million 22.88%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$124.33 - $156.75 $251,643 - $317,262
-2,024 Reduced 2.44%
80,921 $10.1 Million
Q2 2024

Aug 14, 2024
SELL
$113.33 - $163.85 $223,940 - $323,767
-1,976 Reduced 2.33%
82,945 $13.1 Million
Q1 2024

May 15, 2024
SELL
$93.7 - $141.53 $55,376 - $83,644
-591 Reduced 0.69%
84,921 $11 Million
Q4 2023

Feb 13, 2024
SELL
$67.31 - $124.76 $297,442 - $551,314
-4,419 Reduced 4.91%
85,512 $8.25 Million
Q3 2023

Nov 14, 2023
SELL
$102.5 - $123.59 $604,442 - $728,810
-5,897 Reduced 6.15%
89,931 $10.9 Million
Q2 2023

Aug 21, 2023
SELL
$106.4 - $157.19 $1.03 Million - $1.51 Million
-9,637 Reduced 9.14%
95,828 $11 Million
Q1 2023

May 09, 2023
SELL
$117.53 - $155.99 $168,185 - $223,221
-1,431 Reduced 1.34%
105,465 $14.5 Million
Q4 2022

Feb 14, 2023
SELL
$100.86 - $132.13 $259,109 - $339,441
-2,569 Reduced 2.35%
106,896 $13.9 Million
Q3 2022

Nov 18, 2022
BUY
$75.71 - $119.24 $201,388 - $317,178
2,660 Added 2.49%
109,465 $12.1 Million
Q2 2022

Aug 15, 2022
BUY
$62.69 - $88.44 $23,884 - $33,695
381 Added 0.36%
106,805 $8.01 Million
Q1 2022

May 16, 2022
SELL
$63.15 - $90.42 $215,215 - $308,151
-3,408 Reduced 3.1%
106,424 $8.31 Million
Q4 2021

Feb 15, 2022
SELL
$77.28 - $99.42 $1.45 Million - $1.86 Million
-18,748 Reduced 14.58%
109,832 $9.89 Million
Q3 2021

Nov 15, 2021
SELL
$65.97 - $92.48 $278,459 - $390,358
-4,221 Reduced 3.18%
128,580 $11.9 Million
Q2 2021

Aug 16, 2021
SELL
$69.38 - $86.75 $630,525 - $788,384
-9,088 Reduced 6.41%
132,801 $10.3 Million
Q1 2021

May 18, 2021
BUY
$72.25 - $168.95 $61,773 - $144,452
855 Added 0.61%
141,889 $10.6 Million
Q4 2020

Feb 16, 2021
BUY
$125.56 - $178.74 $543,925 - $774,301
4,332 Added 3.17%
141,034 $24 Million
Q3 2020

Nov 17, 2020
SELL
$127.12 - $172.34 $283,350 - $384,145
-2,229 Reduced 1.6%
136,702 $19.2 Million
Q2 2020

Aug 17, 2020
BUY
$93.0 - $171.7 $1.34 Million - $2.47 Million
14,357 Added 11.52%
138,931 $22.3 Million
Q1 2020

May 13, 2020
SELL
$82.38 - $131.64 $259,991 - $415,455
-3,156 Reduced 2.47%
124,574 $12.2 Million
Q4 2019

Feb 14, 2020
BUY
$76.53 - $135.58 $1.08 Million - $1.91 Million
14,099 Added 12.41%
127,730 $16.5 Million
Q3 2019

Nov 15, 2019
BUY
$72.81 - $156.91 $98,584 - $212,456
1,354 Added 1.21%
113,631 $8.56 Million
Q2 2019

Aug 14, 2019
BUY
$112.21 - $151.95 $814,083 - $1.1 Million
7,255 Added 6.91%
112,277 $17.1 Million
Q1 2019

May 09, 2019
BUY
$106.67 - $151.68 $49,174 - $69,924
461 Added 0.44%
105,022 $12.5 Million
Q4 2018

Feb 13, 2019
BUY
$97.32 - $148.76 $776,224 - $1.19 Million
7,976 Added 8.26%
104,561 $11.4 Million
Q3 2018

Nov 14, 2018
BUY
$115.31 - $161.51 $148,980 - $208,670
1,292 Added 1.36%
96,585 $15.6 Million
Q2 2018

Aug 14, 2018
BUY
$71.74 - $153.69 $159,262 - $341,191
2,220 Added 2.39%
95,293 $12.6 Million
Q1 2018

May 15, 2018
SELL
$54.02 - $82.27 $176,267 - $268,447
-3,263 Reduced 3.39%
93,073 $6.9 Million
Q4 2017

Feb 14, 2018
BUY
$47.64 - $56.75 $74,604 - $88,870
1,566 Added 1.65%
96,336 $5.36 Million
Q3 2017

Nov 13, 2017
BUY
$35.73 - $47.15 $3.39 Million - $4.47 Million
94,770
94,770 $4.3 Million

Others Institutions Holding SRPT

# of Institutions
530
Shares Held
84.5M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11.1B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email